|
|
||||||||
1 Department of Radiology, Asan Medical Center, University of Ulsan College of
Medicine, 388-1 Poongnapdong, Songpa-gu, Seoul, 138-736, South Korea.
2 Department of Neurosurgery, Asan Medical Center, University of Ulsan College
of Medicine, Seoul, 138-736, South Korea.
3 Department of Radiology, Armed Forces Capital Hospital, San 13-4 Yooldong,
Boondang-gu, Seongnam, Seoul, 463-040, South Korea.
4 Department of Information and Statistics, Daejeon University, 96-3
Yongwoo-dong, Daejeon, 300-716, Korea.
OBJECTIVE. Relative cerebral blood flow has rarely been studied as part of the preoperative assessment of tumor grade, although relative cerebral blood volume is known to be useful for this assessment. The purpose of our study was to determine the usefulness of relative cerebral blood flow in assessing the histopathologic grade of cerebral gliomas.
SUBJECTS AND METHODS. MR imaging was performed in 17 patients with proven cerebral gliomas (11 high-grade gliomas and six low-grade gliomas), using a first-pass gadopentetate dimeglumineenhanced T2-weighted echoplanar perfusion sequence. The perfusion data were deconvoluted with an arterial input function, using singular value decomposition to obtain a color map of relative cerebral blood volume and flow; the relative cerebral blood volume and flow ratios were expressed relative to values measured in the contralateral white matter. The Wilcoxon's rank sum test was performed to test the difference between the mean of the relative cerebral blood volume (or flow) ratio in high-grade gliomas and that in low-grade gliomas. Receiver operating characteristic curve analysis was used to evaluate the association between the relative cerebral blood volume (or flow) ratio and the grade of the glioma, as well as to calculate the relative cerebral blood volume and flow ratio cutoff value permitting discrimination between high- and low-grade gliomas. The correlation between relative cerebral blood volume and flow ratios was evaluated using Spearman's rank correlation analysis. We also made a qualitative assessment regarding the match or mismatch of areas of maximal contrast enhancement with the areas of highest color perfusion maps.
RESULTS. The mean of the relative cerebral blood volume ratio was 4.91 in the high-grade gliomas and 2.00 in the low-grade gliomas. The mean relative cerebral blood flow ratio was 4.82 in the high-grade gliomas and 1.83 in the low-grade gliomas. A significant difference in each relative cerebral blood volume and flow ratio was found between the high- and low-grade gliomas (Wilcoxon's rank sum test, p < 0.05). Both the relative cerebral blood volume and flow ratios strongly matched the grade of the glioma, but the difference between the two areas was not significant (receiver operating characteristic curve analysis, p > 0.05). The desired cutoff value was 2.93 in the relative cerebral blood volume ratio and 3.57 in the relative cerebral blood flow ratio. Additionally, there was a strong correlation between the relative cerebral blood volume and flow ratios (Spearman's rank correlation coefficient = 0.762; p < 0.05). There was frequent mismatch (33%) between the qualitative assessment of the contrast-enhanced T1-weighted MR images and the perfusion maps.
CONCLUSION. First-pass gadopentetate dimeglumineenhanced T2-weighted echoplanar perfusion MR imaging is useful for the preoperative assessment of tumor grade. A relative cerebral blood flow ratio, in addition to a relative cerebral blood volume ratio, can be a useful tool in the evaluation of the histopathologic grade of cerebral gliomas.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Law, R. J. Young, J. S. Babb, N. Peccerelli, S. Chheang, M. L. Gruber, D. C. Miller, J. G. Golfinos, D. Zagzag, and G. Johnson Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging Radiology, May 1, 2008; 247(2): 490 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.K. Ellika, R. Jain, S.C. Patel, L. Scarpace, L.R. Schultz, J.P. Rock, and T. Mikkelsen Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1981 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, R. Young, J. Babb, E. Pollack, and G. Johnson Histogram Analysis versus Region of Interest Analysis of Dynamic Susceptibility Contrast Perfusion MR Imaging Data in the Grading of Cerebral Gliomas AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 761 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, R. Young, J. Babb, M. Rad, T. Sasaki, D. Zagzag, and G. Johnson Comparing Perfusion Metrics Obtained from a Single Compartment Versus Pharmacokinetic Modeling Methods Using Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade. AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 1975 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Weber, S. Zoubaa, M. Schlieter, E. Juttler, H. B. Huttner, K. Geletneky, C. Ittrich, M. P. Lichy, A. Kroll, J. Debus, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors Neurology, June 27, 2006; 66(12): 1899 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. Mills, T.A. Patankar, H.A. Haroon, D. Baleriaux, R. Swindell, and A. Jackson Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.L. Boxerman, K.M. Schmainda, and R.M. Weisskoff Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 859 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bullitt, P.A. Wolthusen, L. Brubaker, W. Lin, D. Zeng, and T. Van Dyke Malignancy-Associated Vessel Tortuosity: A Computer-Assisted, MR Angiographic Study of Choroid Plexus Carcinoma in Genetically Engineered Mice AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 612 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, S. Oh, J. S. Babb, E. Wang, M. Inglese, D. Zagzag, E. A. Knopp, and G. Johnson Low-Grade Gliomas: Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging--Prediction of Patient Clinical Response Radiology, February 1, 2006; 238(2): 658 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Patankar, H. A. Haroon, S. J. Mills, D. Baleriaux, D. L. Buckley, G. J.M. Parker, and A. Jackson Is Volume Transfer Coefficient (Ktrans) Related to Histologic Grade in Human Gliomas? AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2455 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bulakbasi, M. Kocaoglu, A. Farzaliyev, C. Tayfun, T. Ucoz, and I. Somuncu Assessment of Diagnostic Accuracy of Perfusion MR Imaging in Primary and Metastatic Solitary Malignant Brain Tumors AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2187 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Brubaker, E. Bullitt, C. Yin, T. Van Dyke, and W. Lin Magnetic Resonance Angiography Visualization of Abnormal Tumor Vasculature in Genetically Engineered Mice Cancer Res., September 15, 2005; 65(18): 8218 - 8223. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Covarrubias, B. R. Rosen, and M. H. Lev Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors Oncologist, September 1, 2004; 9(5): 528 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, K. Kazmi, S. Wetzel, E. Wang, C. Iacob, D. Zagzag, J. G. Golfinos, and G. Johnson Dynamic Susceptibility Contrast-Enhanced Perfusion and Conventional MR Imaging Findings for Adult Patients with Cerebral Primitive Neuroectodermal Tumors AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 997 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, S. Yang, J. S. Babb, E. A. Knopp, J. G. Golfinos, D. Zagzag, and G. Johnson Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 746 - 755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Law, S. Yang, H. Wang, J. S. Babb, G. Johnson, S. Cha, E. A. Knopp, and D. Zagzag Glioma Grading: Sensitivity, Specificity, and Predictive Values of Perfusion MR Imaging and Proton MR Spectroscopic Imaging Compared with Conventional MR Imaging AJNR Am. J. Neuroradiol., November 1, 2003; 24(10): 1989 - 1998. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |